Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$2.13 - $7.13 $4,899 - $16,399
-2,300 Reduced 17.97%
10,500 $25,000
Q1 2023

May 16, 2023

SELL
$5.52 - $9.23 $34,776 - $58,149
-6,300 Reduced 32.98%
12,800 $73,000
Q4 2022

Feb 14, 2023

SELL
$7.72 - $21.27 $136,644 - $376,479
-17,700 Reduced 48.1%
19,100 $170,000
Q3 2022

Nov 14, 2022

SELL
$13.43 - $18.74 $135,643 - $189,273
-10,100 Reduced 21.54%
36,800 $523,000
Q2 2022

Aug 15, 2022

BUY
$10.26 - $20.81 $216,486 - $439,091
21,100 Added 81.78%
46,900 $685,000
Q1 2022

May 16, 2022

BUY
$11.53 - $19.97 $297,474 - $515,225
25,800 New
25,800 $515,000

Others Institutions Holding ACET

About Adicet Bio, Inc.


  • Ticker ACET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,030,800
  • Market Cap $38M
  • Description
  • Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...
More about ACET
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.